好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Predictors of Outcome in Patients with Acute M2 Occlusion
Cerebrovascular Disease and Interventional Neurology
(-)
149
Authors/Disclosures
Muhib Khan, MD, FAAN (Mayo Clinic)
PRESENTER
The institution of Dr. Khan has received research support from Mayo Clinic 好色先生 Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
No disclosure on file
Jiaying Zhang, MD (TeleSpecialist) Dr. Zhang has nothing to disclose.
Majaz Moonis, MD, FAHA, FAAN (University of Massachusetts, Department of Neurology) Dr. Moonis has nothing to disclose.
Richard P. Goddeau, Jr., DO (UMass Medical Center) No disclosure on file
Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center) Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.